“The World Health Organization said Thursday that governments in the Mekong region must act ‘urgently’ to stop the spread of drug-resistant malaria which has emerged in parts of Vietnam and Myanmar,” Agence France-Presse reports. “There is growing evidence that the malaria parasite is becoming resistant to a frontline treatment, the anti-malarial drug artemisinin, in southern and central Vietnam and in southeastern Myanmar, the WHO said in a statement,” AFP writes, noting, “WHO regional director, Shin Young-soo, said countries must ‘urgently address this issue before we put at risk not only the fragile gains we have made in malaria control but also our goal of a malaria-free Western Pacific Region.'” The news service adds, “Countries in the Mekong region must ‘intensify and expand’ operations to contain and eliminate artemisinin-resistant malaria, Shin said at a WHO regional meeting in Hanoi” (9/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.